Posted by glaucoma doctor in Glaucoma news
“
In summary, histopathology of eyes with Rb following IAC showed evidence of complete tumor regression in eyes in which there was clinical tumor regression and also confirmed viable tumor in those in which tumor was suspected clinically,” report the authors. However, the authors also emphasize the importance of the discovery of blood vessel blockages and foreign material in the clots within those vessels. The researchers conclude, “We suggest that IAC for Rb be used with caution.”
Ralph C. Eagle, Jr., M.D., from the Wills Eye Institute, Philadelphia, and colleagues examined...
Posted by glaucoma doctor in Glaucoma news
Glaucoma continues to have existence a greater end of blindness and seeing deprivation as well-as; not only-but also; not only-but; not alone-but worldwide and in the United States, in what place some estimated 2.2 the masses the vulgar receive the disease.
People with the top risk factors for the disease need to be especially vigilant. A recent National Eye Institute report found that fewer than 10 percent of Americans surveyed knew that glaucoma has no early warning signs, in most cases. “Glaucoma’s silent onset is a key reason the disease so often damages vision before people know they...
Posted by glaucoma doctor in Glaucoma news
San Francisco – November 2, 2009 – The Glaucoma Careful search Settlement announced today that Adrienne L. Graves, PhD has been appointed to its Meals of Directors.
Kuldev Singh, MD, MPH, Plank Professorship of the Glaucoma Exploration Footing and Guide of Glaucoma Employment and Professor of Ophthalmology at Stanford University, commented, “Having observed the quality of Dr. Graves’ work as a scientist and CEO, I feel she brings tremendous energy, experience and qualifications to the board.”
Thomas M. Brunner, President and CEO of the Glaucoma Research Foundation,...
Posted by glaucoma doctor in Glaucoma news
Each between nations team, led through . researchers from the Universal school of California, San Diego Instruct of Remedy and the Public Vigilance Pass, has discovered gene variants as antidote to glaucoma in a black population.
The study was conducted by Kang Zhang, MD, PhD, Director of the Institute for Genomic Medicine and professor of ophthalmology and human genetics at the Shiley Eye Center at UC San Diego and J. Fielding Hejtmancik, MD, PhD, medical officer and chief of the Ophthalmic Molecular Genetics Section at the National Eye Institute, National Institutes of Health, along with the Barbados...
Posted by glaucoma doctor in Glaucoma news
Patients were followed up for a median of nine years (the range was 3.2 to 13 years). The high-frequency data set had a median number of visual field examinations of 20; for the low-frequency data set, this median number was 12. Researchers determined that the high-frequency data set was more likely to detect progression. Improvement was also detected in some eyes. When data were censored (curtailed to account for partially unknown values) at five years, the results did not change significantly.
Kouros Nouri-Mahdavi, M.D., M.Sc., and colleagues from the Jules Stein Eye Institute, University of...
